Cyanosis classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(10 intermediate revisions by 2 users not shown)
Line 2: Line 2:
{{Cyanosis}}
{{Cyanosis}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{Sara.Zand}} {{ADS}}  
==Overview==
==Overview==
There is no established system for the classification of [disease name].
[[Cyanosis]] is defined as bluish discoloration of the [[skin]] and or mucous membrane resulting from insufficient [[oxygenation]] of the [[blood]] and the presence of at least 5g/dl unsaturated [[hemoglobin]] in tissue. [[Anemia]] may lead to [[hypoxia]] but is not the cause of [[cyanosis]]. Right to left shunt in [[congenital heart disease]] causes [[central cyanosis]]. [[Secondary erythrocytosis]] (increased [[red blood cell mass ]] due to [[hypoxia]]) and [[polycythemia]] (neoplastic proliferation of [[reb blood cell]]) are different conditions  and need different evaluation. [[Cyanosis]] may be  classified into [[central cyanosis]] and [[peripheral cyanosis]].
 
OR
 
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
 
OR
 
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
 
OR
 
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
 
OR
 
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
 
OR
 
The staging of [malignancy name] is based on the [staging system].
 
OR
 
There is no established system for the staging of [malignancy name].


==Classification==
==Classification==
 
*Cyanosis may be classified into two groups:<ref name="McMullenPatrick2013">{{cite journal|last1=McMullen|first1=Sarah M.|last2=Patrick|first2=Ward|title=Cyanosis|journal=The American Journal of Medicine|volume=126|issue=3|year=2013|pages=210–212|issn=00029343|doi=10.1016/j.amjmed.2012.11.004}}</ref>
*There is no established system for the classification of [disease name].
:*[[Peripheral cyanosis]] affecting hands and feet
OR
:*Central cyanosis affecting mucous membrane, [[lips]], [[tongue]] and [[sublingual tissue]]
*[Disease name] may be classified according to [classification method] into [number] subtypes/groups:  
**[Group1]
**[Group2]
**[Group3]
**[Group4]
OR
*[Disease name] may be classified into [large number > 6] subtypes based on:
**[Classification method 1]
**[Classification method 2]
**[Classification method 3]
*[Disease name] may be classified into several subtypes based on:  
**[Classification method 1]
**[Classification method 2]
**[Classification method 3]
OR
*Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
*If the staging system involves specific and characteristic findings and features:
*According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
*The staging of [malignancy name] is based on the [staging system].
OR
*There is no established system for the staging of [malignancy name].


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WH}}
 
{{WS}}
[[Category:Primary care]]
[[Category: (name of the system)]]

Latest revision as of 04:05, 26 December 2020

Cyanosis Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cyanosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cyanosis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cyanosis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cyanosis classification

CDC on Cyanosis classification

Cyanosis classification in the news

Blogs on Cyanosis classification

Directions to Hospitals Treating Cyanosis

Risk calculators and risk factors for Cyanosis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Amandeep Singh M.D.[3]

Overview

Cyanosis is defined as bluish discoloration of the skin and or mucous membrane resulting from insufficient oxygenation of the blood and the presence of at least 5g/dl unsaturated hemoglobin in tissue. Anemia may lead to hypoxia but is not the cause of cyanosis. Right to left shunt in congenital heart disease causes central cyanosis. Secondary erythrocytosis (increased red blood cell mass due to hypoxia) and polycythemia (neoplastic proliferation of reb blood cell) are different conditions and need different evaluation. Cyanosis may be classified into central cyanosis and peripheral cyanosis.

Classification

  • Cyanosis may be classified into two groups:[1]

References

  1. McMullen, Sarah M.; Patrick, Ward (2013). "Cyanosis". The American Journal of Medicine. 126 (3): 210–212. doi:10.1016/j.amjmed.2012.11.004. ISSN 0002-9343.